This open-label, phase 1/2a study evaluates the safety and activity of fully human glucocorticoid-induced tumor necrosis factor (TNF) receptor–related protein agonist immunoglobulin G1 monoclonal antibody BMS-986156 with or without nivolumab in patients with advanced solid tumors.
This cluster-randomized clinical trial examines whether providing a geriatric assessment summary and geriatric assessment–guided recommendations to oncologists can improve communication about aging-related concerns.
This cross-sectional study weighs the proportional associations of rising drug costs and use with increased Medicare Part D spending for a cohort of oral anticancer drugs used from 2013 through 2017.
This review describes the development and use of axicabtagene ciloleucel for treatment in patients with refractory large B-cell lymphoma.
This Viewpoint advocates for additional awareness and allocation of resources to address the increasing incidence of neuroendocrine tumors.
Create a personal account or sign in to: